R. González-Aparicio

ATP13A2 levels in serum and cerebrospinal fluid in patients with idiopathic Parkinson's disease.

J. Suárez, F. Rodríguez de Fonseca, A. Santurtún, 2021, Parkinsonism & Related Disorders.

Oleoylethanolamide reduces L-DOPA-induced dyskinesia via TRPV1 receptor in a mouse model of Parkinson´s disease

R. Moratalla, R. González-Aparicio, 2014, Neurobiology of Disease.

Oleoylethanolamide exerts partial and dose-dependent neuroprotection of substantia nigra dopamine neurons

P. Robledo, R. Maldonado, F. Bermúdez-Silva, 2009, Neuropharmacology.

The systemic administration of oleoylethanolamide exerts neuroprotection of the nigrostriatal system in experimental Parkinsonism.

P. Robledo, L. Parsons, R. Maldonado, 2014, The international journal of neuropsychopharmacology.

Mice lacking the peroxisome proliferator-activated receptor alpha gene present reduced number of dopamine neurons in the substantia nigra without altering motor behavior or dopamine neuron decline over life

I. Tasset, I. Túnez, E. Fernández-Espejo, 2011, Neuroscience.

Antiparkinsonian trophic action of glial cell line-derived neurotrophic factor and transforming growth factor β1 is enhanced after co-infusion in rats

E. Fernández-Espejo, R. González-Aparicio, J. A. Flores, 2010, Experimental Neurology.

Grafts of extra-adrenal chromaffin cells as aggregates show better survival rate and regenerative effects on parkinsonian rats than dispersed cell grafts

I. Tasset, S. Ramiro-Fuentes, E. Fernández-Espejo, 2008, Neurobiology of Disease.